Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,303
  • Shares Outstanding, K 14,781
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,980 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.97
Trade MIRA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.55
  • Most Recent Earnings $-0.19 on 04/01/24
  • Latest Earnings Date 01/05/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7600 +13.13%
on 04/16/24
1.1800 -27.14%
on 03/28/24
-0.2902 (-25.23%)
since 03/26/24
3-Month
0.7600 +13.13%
on 04/16/24
1.8400 -53.27%
on 03/11/24
-0.2302 (-21.12%)
since 01/26/24

Most Recent Stories

More News
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 0.8598 (-4.47%)
CARA : 0.6843 (-2.24%)
CRBP : 34.25 (+2.24%)
HRMY : 29.32 (+1.35%)
JAZZ : 109.46 (+1.89%)
MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication Efforts

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals to Ring the Nasdaq Opening Bell on Wednesday, August 9, 2023

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals, Inc. Announces Closing of $8.9 Million Initial Public Offering

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial Public Offering and Nasdaq Listing

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 0.8598 (-4.47%)
GURU Announces Closing of Subscription Receipt Financing

Company raises $34.5 million for its Canadian and U.S. expansion in advance of its Going Public Transaction

MIRA : 0.8598 (-4.47%)
MIRA-P.VN : 0.025 (-50.00%)

Business Summary

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline...

See More

Key Turning Points

3rd Resistance Point 0.9684
2nd Resistance Point 0.9427
1st Resistance Point 0.9013
Last Price 0.8598
1st Support Level 0.8342
2nd Support Level 0.8085
3rd Support Level 0.7671

See More

52-Week High 7.9799
Fibonacci 61.8% 5.2219
Fibonacci 50% 4.3699
Fibonacci 38.2% 3.5180
Last Price 0.8598
52-Week Low 0.7600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar